CHARLES SCHWAB INVESTMENT MANAGEMENT INC - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 159 filers reported holding MERSANA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.9%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$373,894
-86.2%
294,405
-64.1%
0.00%
-100.0%
Q2 2023$2,700,064
-10.0%
820,688
+12.5%
0.00%0.0%
Q1 2023$2,998,948
-23.7%
729,671
+8.7%
0.00%0.0%
Q4 2022$3,932,218
-9.6%
671,027
+4.3%
0.00%
-50.0%
Q3 2022$4,352,000
+43.5%
643,645
-1.9%
0.00%
+100.0%
Q2 2022$3,032,000
+63.5%
656,164
+41.2%
0.00%0.0%
Q1 2022$1,854,000
-38.9%
464,660
-4.8%
0.00%0.0%
Q4 2021$3,036,000
-33.3%
488,005
+1.2%
0.00%0.0%
Q3 2021$4,549,000
-18.8%
482,310
+16.9%
0.00%
-50.0%
Q2 2021$5,602,000
-6.5%
412,473
+11.4%
0.00%0.0%
Q1 2021$5,990,000
-37.2%
370,183
+3.3%
0.00%
-50.0%
Q4 2020$9,534,000
+44.8%
358,252
+1.4%
0.00%
+33.3%
Q3 2020$6,582,000
+136.9%
353,475
+197.8%
0.00%
+200.0%
Q2 2020$2,778,000
+453.4%
118,689
+37.8%
0.00%
Q1 2020$502,000
+2.9%
86,105
+1.2%
0.00%
Q4 2019$488,000
+261.5%
85,0450.0%0.00%
Q3 2019$135,000
-60.9%
85,0450.0%0.00%
Q2 2019$345,000
+87.5%
85,045
+144.0%
0.00%
Q1 2019$184,000
+84.0%
34,850
+42.2%
0.00%
Q4 2018$100,000
-64.4%
24,500
-12.8%
0.00%
Q3 2018$281,000
-35.8%
28,100
+14.7%
0.00%
Q2 2018$438,000
+36.4%
24,500
+20.7%
0.00%
Q1 2018$321,00020,3000.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,005,600$64,810,0006.21%
Bain Capital Life Sciences Investors, LLC 3,695,667$59,796,0003.39%
COMMODORE CAPITAL LP 429,228$6,945,0002.77%
ACUTA CAPITAL PARTNERS, LLC 357,689$5,787,0002.09%
Avoro Capital Advisors LLC 6,800,000$110,024,0001.90%
Ghost Tree Capital, LLC 450,000$7,281,0001.71%
RHO CAPITAL PARTNERS INC 796,458$12,887,0001.24%
Rock Springs Capital Management LP 2,775,127$44,902,0000.98%
Sio Capital Management, LLC 157,259$2,544,0000.52%
Bellevue Group AG 2,850,010$46,113,0000.49%
View complete list of MERSANA THERAPEUTICS INC shareholders